La bourse est fermée

Baxter International Inc. (BAX)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
33,90-0,10 (-0,29 %)
À la clôture : 04:00PM EDT
34,00 +0,10 (+0,29 %)
Échanges après Bourse : 06:44PM EDT

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000
https://www.baxter.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein60 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Jose E. AlmeidaChairman of the Board, President & CEO3,62MS.O.1962
Mr. Joel T. GradeExecutive VP & CFO829,82kS.O.1971
Ms. Heather KnightExecutive VP & Group President of Medical Products and Therapies1,63MS.O.1972
Mr. Alok Sonig B.E., MbaExecutive VP & Group President of Pharmaceuticals1,56MS.O.1972
Mr. Christopher A. TothExecutive VP & Group President of Kidney Care5,26MS.O.1980
Ms. Tobi Karchmer M.D., M.S.Senior VP and Chief Medical & Scientific OfficerS.O.S.O.S.O.
Ms. Clare TrachtmanVice President of Investor RelationsS.O.S.O.S.O.
Mr. David S. RosenbloomExecutive VP & General Counsel776,51kS.O.1960
Ms. Stacey Eisen?Senior Vice President, Chief Communications Officer & Corporate Marketing?S.O.S.O.S.O.
Ms. Jeanne K. Mason Ph.D.?Executive VP & Chief Human Resources Officer1,99MS.O.1956
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Baxter International Inc. en date du 1 mai 2024 est 4. Les scores principaux sont Audit : 5; Société : 5; Droits des actionnaires : 1; Compensation : 8.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.